Your browser doesn't support javascript.
loading
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
Ringdén, Olle; Brazauskas, Ruta; Wang, Zhiwei; Ahmed, Ibrahim; Atsuta, Yoshiko; Buchbinder, David; Burns, Linda J; Cahn, Jean-Yves; Duncan, Christine; Hale, Gregory A; Halter, Joerg; Hayashi, Robert J; Hsu, Jack W; Jacobsohn, David A; Kamble, Rammurti T; Kamani, Naynesh R; Kasow, Kimberly A; Khera, Nandita; Lazarus, Hillard M; Loren, Alison W; Marks, David I; Myers, Kasiani C; Ramanathan, Muthalagu; Saber, Wael; Savani, Bipin N; Schouten, Harry C; Socie, Gérard; Sorror, Mohamed L; Steinberg, Amir; Popat, Uday; Wingard, John R; Mattsson, Jonas; Majhail, Navneet S.
Afiliação
  • Ringdén O; Center for Allogeneic Stem Cell Transplantation, Karolinka University Hospital, Stockholm, Sweden.
  • Brazauskas R; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Wang Z; Center for International Bone and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Ahmed I; Department of Pediatric Hematology & Oncology, University of New Mexico, Albuquerque, New Mexico.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Buchbinder D; Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, California.
  • Burns LJ; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Cahn JY; Clinique Universitaire d'Hématologie, University Hospital, Grenoble, France.
  • Duncan C; Pediatric Stem Cell Transplantation Program, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Hale GA; Department of Hematology Oncology, All Children's Hospital, St. Petersburg, Florida.
  • Halter J; Department of Hematology, University Hospital Basel, Basel, Switzerland.
  • Hayashi RJ; Division of Pediatric Hematology/Oncology, Washington University, St. Louis Children's Hospital, St. Louis, Missouri.
  • Hsu JW; Division of Hematology & Oncology, Shands HealthCare, University of Florida, Gainesville, Florida.
  • Jacobsohn DA; Division of Blood and Marrow Transplantation, Children's National Medical Center, Washington, DC.
  • Kamble RT; Center for Gene Therapy, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, Texas.
  • Kamani NR; AABB Center for Cellular Therapies, Bethesda, Maryland.
  • Kasow KA; Pediatric Bone Marrow Transplantation Program, University of North Carolina Hospitals, Chapel Hill, North Carolina.
  • Khera N; Department of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
  • Lazarus HM; Division of Hematology and Oncology, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio.
  • Loren AW; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Marks DI; Adult BMT Unit, Bristol Children's Hospital, Bristol, United Kingdom.
  • Myers KC; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Ramanathan M; Division of Hematology/Oncology, UMass Memorial Medical Center, Worcester, Massachusetts.
  • Saber W; Center for International Bone and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Savani BN; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schouten HC; Department of Medicine and Hematology, Academische Ziekenhuis Maastricht, Maastricht, Netherlands.
  • Socie G; Service d'Hematologie-Greffe de Moelle, Hopital Saint Louis, Paris, France.
  • Sorror ML; Clinical Research Division, Fred Hutchinson Cancer Research Center, and Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Steinberg A; Department of Hematology and Medical Oncology, Mount Sinai Medical Center, Los Angeles, California.
  • Popat U; Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, Texas.
  • Wingard JR; Division of Hematology & Oncology, Shands HealthCare, University of Florida, Gainesville, Florida.
  • Mattsson J; Center for Allogeneic Stem Cell Transplantation, Karolinka University Hospital, Stockholm, Sweden.
  • Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio. Electronic address: majhain@ccf.org.
Biol Blood Marrow Transplant ; 20(11): 1777-84, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25042734
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article